dTMS for Subjective Cognitive Decline

Inclusion Criteria: have a family history of late onset sporadic Alzheimer's disease (AD) as defined by having a first degree relative, living or deceased, with a probable or confirmed diagnosis of AD have subjective memory decline and concern about memory changes score 26 or higher on the Montreal Cognitive Assessment (MoCA) are willing to provide informed consent are able to follow the treatment schedule are stable on medications for 2 months and are not expected to change medication during the entire study period (if they are taking medications) have a satisfactory safety screening questionnaire for TMS have an informant/study partner who is able to complete study questionnaires regarding the participant Exclusion Criteria: have a metal plate in their head, except in the mouth (such as an ear implant, implanted brain stimulators, aneurysm clips) have known increased pressure or a history of increased pressure in their brain, which may increase their risk for having seizures have a cardiac pacemaker have an implanted medication pump have a central venous line have a significant heart condition have current depression or a history of any psychotic disorder, bipolar disorder, eating disorder, obsessive compulsive disorder, post-traumatic stress disorder, or dementia other than AD have a history of substance abuse in the last 6 months have a history of stroke or other brain lesions have a personal history of epilepsy have a family history of epilepsy are a pregnant or breast-feeding woman have a history of abnormal MRI of the brain have significant hearing loss requiring use of hearing aids have untreated hypo- or hyper-thyroidism have TMS contraindications have unstable medical condition(s) regularly use benzodiazepines or other hypnotics within 2 weeks of randomization